Crunching the numbers for GPCR... Refresh in a moment for the full analysis.

Structure Therapeutics Inc. (GPCR)

weak

$54.51

Updated: 2026-04-13

TradeApes Score

reduce

Financial Strength

35 Weak

Operating Trend

30 Weak

Valuation

40 Weak

Capital Allocation

30 Weak

Risk

65 Healthy

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

− High leverage — net debt/EBITDA between 3× and 5×

See the full analysis

Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.

Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.